Truphone to Lead an Invisible Revolution at Mobile World Congress 2023
Truphone, the pioneering global connectivity provider, today announced it will be showcasing its industry-leading innovations at the upcoming Mobile World Congress (MWC) event in Barcelona, from February 27th to March 2nd, 2023.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230222005594/en/
Truphone to Lead an Invisible Revolution at Mobile World Congress 2023 (Graphic: Business Wire)
Presenting from Booth 7B71, Hall 7, Truphone will reveal how it’s driving the “Invisible Revolution” of truly global, seamless cellular connectivity by unveiling products such as eSIM Launch Pad, its world-class Remote SIM Provisioning and Entitlements Server platform that brings even more value to its eSIM offering for mobile carriers and device makers.
They’ll also be presenting a cutting-edge demonstration of how their leadership position on the game-changing new SGP.31 eSIM Internet of Things (IoT) Architecture and Requirements Specification embodies their commitment to delivering choice and freedom. By removing operator lock-in and democratising connectivity for the entire IoT connectivity ecosystem, Truphone is paving the way for new opportunities and growth for cellular IoT technologies.
At the booth, attendees will also have the opportunity to meet with Truphone's senior team and industry experts, as well as Hakan Koç, one of Truphone’s two new co-owners, to learn more about the company's new vision and strategy.
"We’re thrilled to be exhibiting at MWC 2023 and showcasing our latest technologies to the telecommunications industry," said Harry Odenhoven, CEO of Truphone. "We believe that Truphone is at the forefront of transforming the landscape of global cellular connectivity by providing more choice and freedom than any other provider, and we’re excited to demonstrate our commitment to that by sharing our vision for the future."
With a track record of pioneering industry-firsts, Truphone has become one of the world's most respected telecommunications and connectivity companies. By leveraging its global network infrastructure and technology, Truphone is transforming the way businesses and consumers connect and communicate, delivering true mobility and flexibility to its customers.
To learn more about Truphone is driving the Invisible Revolution and helping to shape the way the world connects, visit the company at MWC 2023 at Booth 7B71, Hall 7.
About Truphone
We’re on a mission to connect the world seamlessly.
That’s why we aim to enable more connections than anyone else and why we’ve been pioneering the eSIM revolution from the very beginning.
From international enterprises and consumers to IOT device makers and Telecommunications operators, our global network and connectivity solutions enable people, devices and networks to connect anywhere, instantly, with one platform to connect billions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005594/en/
Contact information
Guy Thornton
Head of Product Marketing
07702 443568
guy.thornton@truphone.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 03:00:00 EET | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 01:34:00 EET | Press release
Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 22:37:00 EET | Press release
500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 18:00:00 EET | Press release
Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 17:57:00 EET | Press release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom